IRIS
DESANTIS, VANESSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.044
AS - Asia 1.927
EU - Europa 1.740
SA - Sud America 525
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 113
OC - Oceania 6
Totale 8.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.828
IT - Italia 837
SG - Singapore 766
BR - Brasile 419
CN - Cina 358
HK - Hong Kong 195
RU - Federazione Russa 176
VN - Vietnam 172
DE - Germania 155
SE - Svezia 132
BD - Bangladesh 123
FR - Francia 117
CA - Canada 101
GB - Regno Unito 91
IN - India 64
FI - Finlandia 55
ID - Indonesia 36
MX - Messico 34
IQ - Iraq 33
NL - Olanda 33
CI - Costa d'Avorio 31
AR - Argentina 29
ZA - Sudafrica 28
TR - Turchia 24
ES - Italia 23
JP - Giappone 22
CO - Colombia 21
PL - Polonia 19
VE - Venezuela 18
LT - Lituania 17
PK - Pakistan 16
AT - Austria 15
EC - Ecuador 13
UZ - Uzbekistan 13
NI - Nicaragua 12
SA - Arabia Saudita 12
TN - Tunisia 12
CR - Costa Rica 11
JO - Giordania 11
MY - Malesia 11
AE - Emirati Arabi Uniti 10
GT - Guatemala 10
MA - Marocco 10
UA - Ucraina 10
IE - Irlanda 9
PH - Filippine 9
CH - Svizzera 8
CL - Cile 8
JM - Giamaica 7
TT - Trinidad e Tobago 7
AU - Australia 6
BE - Belgio 6
HN - Honduras 6
IL - Israele 6
PR - Porto Rico 6
PY - Paraguay 6
CZ - Repubblica Ceca 5
EG - Egitto 5
KE - Kenya 5
NP - Nepal 5
RO - Romania 5
SV - El Salvador 5
AL - Albania 4
AZ - Azerbaigian 4
BH - Bahrain 4
CW - ???statistics.table.value.countryCode.CW??? 4
DK - Danimarca 4
KR - Corea 4
OM - Oman 4
PE - Perù 4
PT - Portogallo 4
SC - Seychelles 4
BB - Barbados 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GP - Guadalupe 3
IR - Iran 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
BF - Burkina Faso 2
BS - Bahamas 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
CD - Congo 1
CU - Cuba 1
CY - Cipro 1
Totale 8.337
Salva come PNG Salva come JPEG
Città #
Ashburn 587
Singapore 438
San Jose 381
Chandler 209
Hong Kong 189
Milan 187
Fairfield 172
Council Bluffs 160
Woodbridge 133
Beijing 128
New York 118
Los Angeles 114
Nyköping 114
Seattle 87
Bari 85
Cambridge 81
Rome 81
Houston 77
Wilmington 65
Dallas 62
Ann Arbor 60
Santa Clara 60
Lauterbourg 57
Ho Chi Minh City 56
Munich 47
Falkenstein 46
Phoenix 46
São Paulo 45
Helsinki 42
Columbus 40
Boardman 34
Buffalo 32
Chicago 32
Abidjan 31
Hanoi 31
Brooklyn 29
Jakarta 27
Figino 26
Lawrence 26
Roxbury 26
Frankfurt am Main 25
Montreal 25
Orem 22
Naples 21
Tokyo 21
Turin 20
Dearborn 19
Johannesburg 19
Nanjing 19
Toronto 19
Atlanta 18
Chennai 18
Denver 18
Inglewood 18
Des Moines 17
Dong Ket 17
London 15
Moscow 15
The Dalles 15
Mexico City 14
Baghdad 13
Curitiba 13
Manchester 13
Rio de Janeiro 13
San Diego 13
Haiphong 12
Marseille 12
Warsaw 12
Washington 12
Amman 11
Bogotá 11
Managua 11
North Bergen 11
Paris 11
Poplar 11
Boston 10
Grafing 10
Tashkent 10
Brescia 9
Campinas 9
Charlotte 9
Florence 9
Giovinazzo 9
Guatemala City 9
Nuremberg 9
Stockholm 9
Ankara 8
Dhaka 8
Dublin 8
Jacksonville 8
Princeton 8
San José 8
Genoa 7
Guangzhou 7
Guarulhos 7
Hebei 7
Jinan 7
Lahore 7
San Francisco 7
Turku 7
Totale 5.021
Salva come PNG Salva come JPEG
Nome #
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 235
Isolation and characterization of neural stem cells from dystrophic mdx mouse 222
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 215
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 207
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 203
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 197
Microenvironment drug resistance in multiple myeloma: Emerging new players 194
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 190
“miRNAs profile of bone marrow fibroblasts in multiple myeloma: relationship with disease progression and drug-resistance” 179
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 174
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 167
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 165
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 165
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 162
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 159
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 149
Diabetes and alzheimer’s disease: Might mitochondrial dysfunction help deciphering the common path? 148
A Challenging Case of Visceral Leishmaniasis 147
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 142
ROLE OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND CORRELATION WITH VASCULAR STIFFNESS AND ORGAN DAMAGE 140
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs 139
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 135
Genomic profiling at a single center cracks the code in inborn errors of immunity 134
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion 133
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 131
Two-year follow-up after drug desensitization in mucopolysaccharidosis 129
Erratum: Corrigendum to “Isolation and characterization of neural stem cells from dystrophic mdx mouse” (Experimental Cell Research (2016) 343(1) (190–207) (S0014482716300593) (10.1016/j.yexcr.2016.03.019)) 129
A Novel Automatic Algorithm to Support Lung Ultrasound Non-Expert Physicians in Interstitial Pneumonia Evaluation: A Single-Center Study 127
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 127
FGF trapping inhibits multiple myeloma growth through c-Myc degradation–induced mitochondrial oxidative stress 124
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 122
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 122
Breaking through Multiple Myeloma: A Paradigm for a Comprehensive Tumor Ecosystem Targeting 120
LIPIDS INCREASE IN HYPERTENSIVES DURING THE FIRST YEAR STEROID TREATMENT FOR GRANULOMATOSIS WITH POLYANGIITIS (GPA) 118
The role of SIRT6 in tumors 118
IMPACT OF REMOTE MONITORING ON PATIENTS’ QUALITY OF LIFE. A SINGLE CENTRE STUDY 109
Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects 109
STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure 109
Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation. 108
Antiangiogenic drugs as chemosensitizers in hematological tumors 108
Changes in Lipids in Granulomatosis with Polyangiitis Relates to Glucocorticoids and History of Hypertension 103
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 103
Targeting the immune microenvironment in Waldenström Macroglobulinemia via halting the CD40/CD40-ligand axis 99
Immune disturbance leads to pulmonary embolism in COVID-19 more than classical risk factors: a clinical and histological study 99
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments 98
Spatial imaging unlocks the potential of charting multiple myeloma and extramedullary disease 97
Epigenetic regulation of angiogenesis in tumor progression 96
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 91
The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value 89
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation 88
MTHFR C677T DEFECT INCREASES SERUM HOMOCYSTEINE LEVELS AND ENDOTHELIAL PROGENITOR CELL (EPCs) DYSFUNCTION IN ATRIAL FIBRILLATION PATIENTS 86
Navigating Lymphomas through BCR Signaling and Double-Hit Insights: Overview 86
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases? 86
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 82
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 79
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies 77
Correlation between atrial cardiomyopathy and predictive biomarkers of cryptogenic stroke in primary and secondary prophylaxis: potential role of endothelial progenitor cell (EPCs) dysfunction 75
GENDER DISPARITIES IN HYPERTENSIVE PATIENTS ACROSS THE LIFETIME: AN AGE-STRATIFIED ANALYSIS 71
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 69
Addressing Endothelial Dysfunction in Heart Failure: The Role of Endothelial Progenitor Cells and New Treatment Horizons 67
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum 67
Mast Cells and Interleukins 66
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature 66
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 64
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 59
Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma 56
Successful rapid desensitization to zoledronic acid in a multiple myeloma patient 53
ATRIOVENTRICULAR BLOCK AND ZANUBRUTINIB: THE ROLE OF CARDIONEUROABLATION 53
"AGLIANICO DEL VULTURE" RED WINE POLYPHENOLIC EXTRACT (RWP) AS DIETARY SUPPLEMENT FOR PREVENTING OBESITY-ASSOCIATED CARDIOMETABOLIC COMPLICATIONS: THE IN VITRO AND IN VIVO PHARMACO-TOXICOLOGICAL PROFILE 53
Visualizing the Interactions Shaping the Imaging of the Microenvironment in Human Cancers 50
PROTECTIVE EFFECTS OF A RED WINE POLYPHENOL EXTRACT OF AGLIANICO DEL VULTURE ON ENDOTHELIAL CELLS AND MACROPHAGES FROM PATIENTS WITH CARDIOMETABOLIC DISEASE 49
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma 44
Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma 41
null 39
STATINS CHANGE miRNA EXPRESSION IN CIRCULATING ENDOTHELIAL PROGENITOR CELLS FROM HYPERTENSIVE PATIENTS 33
Impact of remote monitoring on well-being, therapeutic adherence, and organ damage evaluation in hypertensive patients: the PROSIT study 33
Decoding immune-driven erythroid failure in pure red cell aplasia 22
Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study 19
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease 19
Statin-mediated regulation of vascular microRNA signatures and endothelial progenitor cell function in hypertensive patients 16
Impact of GLP1Ra and SGLT2i on atrial fibrillation in overweight, non-diabetic patients: A meta-analysis of randomized evidence 16
Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysis 16
Impact of frailty on infection risk in non-transplant eligible multiple myeloma patients: a systematic review and meta-analysis 16
Successful rapid intravenous desensitization to rifampicin in a patient with tuberculosis 14
Real-world evidence on infection risk in multiple myeloma treated with BiTEs and CAR-T cells: a meta-analysis 10
Integrating clinical and economic outcomes in the elderly myeloma management: a comparative cost-effectiveness analysis 4
Totale 8.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.249
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022209 0 0 0 0 8 17 14 11 19 26 38 76
2022/2023454 43 78 38 46 35 63 9 56 65 10 9 2
2023/2024277 19 27 17 23 31 105 7 8 0 17 6 17
2024/20251.457 50 24 43 48 52 131 280 153 78 92 177 329
2025/20263.858 457 165 226 380 466 236 371 115 446 390 226 380
2026/20271.365 208 267 290 591 9 0 0 0 0 0 0 0
Totale 8.730